Displaying 11 - 20 of 25
The 117th U.S. Congress is convening at a pivotal moment in the history of our nation. We face a significant set of challenges, but also a momentous opportunity to greatly improve the lives of…
In the new presidential term and the 117th Congress, it is imperative that we have bold, innovative leadership to steer us through one of the biggest health and economic crises in generations and embrace…
Despite notable disparities in health status and access to high-quality health care in communities of color and other minority populations, the United States health care system has not prioritized achieving health equity. Health care…
Authored by: Sophia Tripoli, Director of Health Care Innovation, Families USA; Jen Taylor, Senior Director of Federal Relations, Families USA; Shaun O'Brien, Assistant Director, Research and Collective Bargaining Services, AFSCME; Kelly Trautner, Director, AFT…
If states act quickly, they can significantly lower residents’ health insurance costs by claiming revenue the federal government is about to abandon. In December 2019, Congress ended the federal government’s health insurance assessment (HIA),…
Voters feel that drug prices are out of control and blame drug company greed for the high costs. This issue is personal for many: They tell stories of having to skip expensive medications or…
This guide outlines model policies for states to consider to rein in drug prices in 2019 and beyond. Those discussed first most directly target drug prices and therefore are likely to have the greatest impact.…
State legislative sessions in 2019 bring new opportunities to advance policy that improves health care coverage, value, and equity. With new governors in 17 states, and hundreds of freshman lawmakers, 2019 also brings opportunities…
Health care will be a critical issue in the 2018 elections in many states. Voters will weigh choices for governor in 36 states. In addition, thousands of legislative seats are up in states where…
The U.S. Department of Health and Human Services (HHS) has released a final rule that is dangerous to consumers and to health care marketplaces. This rule would expand the sale of “short-term limited duration plans”…